Article Details

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Retrieved on: 2021-02-01 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange. View article details on hiswai:

Excerpt

... MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, ...

Article found on: financialpost.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up